Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Altria

2 Tobacco Stocks to Buy Before It Gets Too Late

Amid increased health awareness, tobacco usage has declined over the past years. However, the U.S. is still a leading tobacco producer. And given the introduction of new products and sticky consumer habits, the industry should witness stable growth. Thus, investors should buy fundamentally strong tobacco stocks Altria Group (MO) and…

StockNews.com

5 High-Quality Stocks to Buy When There’s Blood on Wall Street

Although the pace of rate hikes could slow, as hinted in the latest Fed statements, a recession still seems imminent. Amid the uncertainties, investors could consider buying high-quality stocks PepsiCo (PEP), United Parcel Service (UPS), Altria Group (MO), Waste Management (WM), and Sprouts Farmers Market (SFM). Keep reading….

StockNews.com

The 4 Best Stocks to Buy for the Rest of 2022

Since the sky-high inflation persisted in September, the Fed is expected to launch another 75-basis-point rate hike this week. The stock market has been under pressure this year as investors remained anxious about the possibility of a recession. However, some fundamentally strong stocks, such as Altria Group (MO), Cummins (CMI),…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

How McKinsey cashed in by consulting for both companies and their regulators

When McKinsey Comes to Town authors Walt Bogdanich and Michael Forsythe say the consulting firm helped companies boost tobacco and opioid sales — while at the same time working for the FDA.

WEKU

EXCLUSIVE: Curaleaf Founder Boris Jordan Says Cannabis Drinks Will Be 50% Of The Industry

The future success of the cannabis industry is directly tied to decriminalization and regulation. That's among the topics being discussed at the 2022 Benzinga Cannabis Capital Conference in Chicago.

Benzinga

Juul just lost a big battle

The e-cigarette company was being investigated by more than 30 states for allegedly marketing its products to youth

Salon

Juul Labs, target of $440 million settlement, has given Illinois pols over $120,000 since 2020

Illinois House Speaker Emanuel ‘Chris’ Welch has been a major recipient of the company’s giving, campaign-finance records show.

Chicago Sun-Times

Read news from The Economist, FT, and more,
with one subscription

This Tobacco Giant Among 3 High Yielding Stocks That Have Increased Dividend Yields To Over 5%

Companies in the S&P 500 that consecutively raise dividends for over 25 years and 50 years, are known as dividend aristocrats and kings, respectively. When hunting for dividend stocks, it can prove to be beneficial investing in corporations that consecutively raise dividends. Here are three dividend stocks that have raised dividend…

Benzinga

The Smartest Tobacco Stock to Buy for the Long Haul

Altria Group (MO) reported weak second-quarter revenues but reaffirmed its EPS guidance range for 2022. While the stock may remain under pressure in the near term due to the broader market volatility, the company’s strong profitability and reasonable valuation make it a solid long-term investment. Read on….

StockNews.com

Altria's $13B Juul investment has lost 95% of its value

Altria reports its nearly $13 billion investment in troubled vaping company Juul is worth 95% less than it originally paid

The Independent UK

Things To Note As Philip Morris (PM) Lines Up For Q2 Earnings

Philip Morris International Inc. (NYSE: PM) is likely to register a top and bottom-line decline when it reports second-quarter 2022 earnings on Jul 21.

Benzinga

What's Going On With Altria Stock Today?

Altria Group Inc (NYSE: MO) shares are trading higher Wednesday after the U.S. Food and Drug Administration temporarily suspended the ban of Juul e-cigarette sales.

Benzinga

Altria is Still a Buy After FDA Orders Pulling JUUL Products Off the Market

Shares of Tobacco giant Altria (MO), a significant stakeholder of Juul Labs, slid last week on the news of the FDA preparing to order removing e-cigarette maker Juul’s products from the U.S. market. However, MO rebounded the following day as investors did not foresee any significant impact of this development…

StockNews.com

FDA orders Juul e-cigarettes off U.S. market

In 2021, FDA removed thousands of electronic cigarettes off U.S. shelves but delayed its decision on Juul.

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The FDA Is Set To Ban Juul Products In U.S.: What Companies Could Benefit?

The U.S.

WEKU

The FDA knows nicotine is addictive. It wants to regulate it for the first time

The Food and Drug Administration is poised to set a maximum nicotine level in cigarettes and some other tobacco products, looking to make them less addictive and wean smokers off the habit.

StockNews.com

5 Inexpensive Blue-Chip Stocks to Add to Your Portfolio

The increasing concerns over a potential recession has kept equities under pressure lately. Given this backdrop, inexpensive blue-chip stocks of Enterprise Products Partners (EPD), Flowers Foods (FLO), The Kroger (KR), Altria Group (MO), and Comcast Corp. (CMCSA) could be solid additions to your portfolio. Continue reading.

Benzinga

Why Altria Stock Is Down More Than 8% Today

Altria Group Inc (NYSE: MO) shares are trading lower Wednesday following reports the U.S. Food and Drug Administration is preparing to remove Juul e-cigarettes from the U.S. market.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

5 Blue Chip Dividend Stocks Yielding More Than 4%

The stock markets pulled back yesterday after the Fed rate hike amid recessionary concerns. Considering the volatile market backdrop, investing in dividend-paying blue-chip stocks AT&T (T), LyondellBasell Industries N.V. (LYB), The Bank of Nova Scotia (BNS), International Business Machines Corp. (IBM), and Altria Group (MO) could be wise.

Benzinga

Why Altria Stock Is Falling Today

Altria Group Inc (NYSE: MO) shares are trading lower Wednesday following bearish analyst coverage from Morgan Stanley.

Tribune News Service

Proposed menthol ban highlights debate over ‘sin tax’ revenue

WASHINGTON — A proposed federal ban on menthol cigarettes has underscored the tension lawmakers face in using so-called “sin tax” revenue to fund critical social programs at the state and federal levels.

Roll Call

Proposed menthol ban highlights debate over ‘sin tax’ revenue - Roll Call

The FDA’s proposed ban on menthol cigarettes means states would see “sin tax” revenues fall, but vaping taxes are already filling the gap.

Benzinga

Marlboro Maker Altria Clocks 2.4% Revenue Decline In Q1; Reaffirms FY22 EPS Outlook

Altria Group Inc (NYSE:MO) reported a first-quarter FY22 sales decline of 2.4% year-on-year to $5.89 billion. Revenues net of excise taxes fell 1.3% to $4.82 billion. Net revenues for smokeable products increased 0.3%, and oral tobacco products fell 2.1%. Total cigarette volume declined 12%, with Marlboro shipment volume down 11.1%. Marlboro retail share…

StockNews.com

4 Top Stocks to Invest in if We Head into a Recession

Lingering supply crunch and soaring inflation have increased the odds of the Fed raising interest rates aggressively later this year, which could dampen corporate earnings. Moreover, as the GDP is estimated to be lower than the prior estimate, many analysts expect the economy to witness recessionary pressure. Therefore, it could…

The Independent UK

Altria says judge has dismissed lawsuit over Juul investment

Altria says an administrative law judge dismissed a federal lawsuit alleging that its investment into vaping company Juul violates anticompetitive laws

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.